These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 8157129)

  • 1. Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol.
    Sparks DL; Scheff SW; Hunsaker JC; Liu H; Landers T; Gross DR
    Exp Neurol; 1994 Mar; 126(1):88-94. PubMed ID: 8157129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APP intracellular domain is increased and soluble Abeta is reduced with diet-induced hypercholesterolemia in a transgenic mouse model of Alzheimer disease.
    George AJ; Holsinger RM; McLean CA; Laughton KM; Beyreuther K; Evin G; Masters CL; Li QX
    Neurobiol Dis; 2004 Jun; 16(1):124-32. PubMed ID: 15207269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in cerebral blood volume and amyloid pathology in aged Alzheimer APP/PS1 mice on a docosahexaenoic acid (DHA) diet or cholesterol enriched Typical Western Diet (TWD).
    Hooijmans CR; Rutters F; Dederen PJ; Gambarota G; Veltien A; van Groen T; Broersen LM; Lütjohann D; Heerschap A; Tanila H; Kiliaan AJ
    Neurobiol Dis; 2007 Oct; 28(1):16-29. PubMed ID: 17720508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model.
    Refolo LM; Malester B; LaFrancois J; Bryant-Thomas T; Wang R; Tint GS; Sambamurti K; Duff K; Pappolla MA
    Neurobiol Dis; 2000 Aug; 7(4):321-31. PubMed ID: 10964604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of simvastatin, atorvastatin and high-cholesterol diet on acetylcholinesterase activity, amyloid beta and cholesterol synthesis in rat brain.
    Cibickova L; Hyspler R; Micuda S; Cibicek N; Zivna H; Jun D; Ticha A; Brcakova E; Palicka V
    Steroids; 2009 Jan; 74(1):13-9. PubMed ID: 18817797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Link between heart disease, cholesterol, and Alzheimer's disease: a review.
    Sparks DL; Martin TA; Gross DR; Hunsaker JC
    Microsc Res Tech; 2000 Aug; 50(4):287-90. PubMed ID: 10936882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta-Amyloid of Alzheimer's disease induces reactive gliosis that inhibits axonal outgrowth.
    Canning DR; McKeon RJ; DeWitt DA; Perry G; Wujek JR; Frederickson RC; Silver J
    Exp Neurol; 1993 Dec; 124(2):289-98. PubMed ID: 8287928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human apoB overexpression and a high-cholesterol diet differently modify the brain APP metabolism in the transgenic mouse model of atherosclerosis.
    Bjelik A; Bereczki E; Gonda S; Juhász A; Rimanóczy A; Zana M; Csont T; Pákáski M; Boda K; Ferdinandy P; Dux L; Janka Z; Sántha M; Kálmán J
    Neurochem Int; 2006 Sep; 49(4):393-400. PubMed ID: 16546298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease.
    Wu ZL; Ciallella JR; Flood DG; O'Kane TM; Bozyczko-Coyne D; Savage MJ
    Neurobiol Aging; 2006 Mar; 27(3):377-86. PubMed ID: 15927307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice.
    Oksman M; Iivonen H; Hogyes E; Amtul Z; Penke B; Leenders I; Broersen L; Lütjohann D; Hartmann T; Tanila H
    Neurobiol Dis; 2006 Sep; 23(3):563-72. PubMed ID: 16765602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol and cognition: rationale for the AD cholesterol-lowering treatment trial and sex-related Differences in beta-amyloid accumulation in the brains of spontaneously hypercholesterolemic Watanabe rabbits.
    Sparks DL; Martins R; Martin T
    Ann N Y Acad Sci; 2002 Nov; 977():356-66. PubMed ID: 12480773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of exogenous cholesterol and lipid-modulating agents on enterocytic amyloid-beta abundance.
    Pallebage-Gamarallage MM; Galloway S; Johnsen R; Jian L; Dhaliwal S; Mamo JC
    Br J Nutr; 2009 Feb; 101(3):340-7. PubMed ID: 18631412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
    Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
    Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prion protein (PrPc) promotes beta-amyloid plaque formation.
    Schwarze-Eicker K; Keyvani K; Görtz N; Westaway D; Sachser N; Paulus W
    Neurobiol Aging; 2005; 26(8):1177-82. PubMed ID: 15917101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient intraneuronal A beta rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice.
    Christensen DZ; Kraus SL; Flohr A; Cotel MC; Wirths O; Bayer TA
    Acta Neuropathol; 2008 Dec; 116(6):647-55. PubMed ID: 18974993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P3 beta-amyloid peptide has a unique and potentially pathogenic immunohistochemical profile in Alzheimer's disease brain.
    Higgins LS; Murphy GM; Forno LS; Catalano R; Cordell B
    Am J Pathol; 1996 Aug; 149(2):585-96. PubMed ID: 8701997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does oxybutynin alter plaques, amyloid beta peptides and behavior in a mouse model of Alzheimer's disease?
    Klausner AP; Sharma S; Fletcher S; Neff P; Yang SK; Son H; Tuttle JB; Steers WD
    J Urol; 2008 Mar; 179(3):1173-7. PubMed ID: 18206173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DHA and cholesterol containing diets influence Alzheimer-like pathology, cognition and cerebral vasculature in APPswe/PS1dE9 mice.
    Hooijmans CR; Van der Zee CE; Dederen PJ; Brouwer KM; Reijmer YD; van Groen T; Broersen LM; Lütjohann D; Heerschap A; Kiliaan AJ
    Neurobiol Dis; 2009 Mar; 33(3):482-98. PubMed ID: 19130883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid beta-peptide and the dementia of Parkinson's disease.
    Jendroska K; Lees AJ; Poewe W; Daniel SE
    Mov Disord; 1996 Nov; 11(6):647-53. PubMed ID: 8914090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease.
    Refolo LM; Pappolla MA; LaFrancois J; Malester B; Schmidt SD; Thomas-Bryant T; Tint GS; Wang R; Mercken M; Petanceska SS; Duff KE
    Neurobiol Dis; 2001 Oct; 8(5):890-9. PubMed ID: 11592856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.